Latest Insider Transactions at Avanos Medical, Inc. (AVNS)
This section provides a real-time view of insider transactions for Avanos Medical, Inc. (AVNS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AVANOS MEDICAL, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AVANOS MEDICAL, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2025
|
Michael Greiner Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
34,316
+13.27%
|
-
|
|
Mar 07
2025
|
Kerr Holbrook SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,877
+18.79%
|
-
|
|
Mar 07
2025
|
John Joseph Hurley Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,961
+14.35%
|
-
|
|
Mar 07
2025
|
Mojirade James SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
19,201
+17.87%
|
-
|
|
Mar 07
2025
|
Sigfrido Delgado SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
10,213
+26.85%
|
-
|
|
Mar 06
2025
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,064
-3.76%
|
$90,960
$15.3 P/Share
|
|
Mar 06
2025
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,000
-7.86%
|
$105,000
$15.25 P/Share
|
|
Mar 06
2025
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,597
-3.39%
|
$203,955
$15.3 P/Share
|
|
Mar 06
2025
|
Joseph Fralin Woody |
SELL
Payment of exercise price or tax liability
|
Direct |
32,076
-3.75%
|
$481,140
$15.3 P/Share
|
|
Mar 06
2025
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
353
-1.76%
|
$5,295
$15.3 P/Share
|
|
Mar 06
2025
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,631
-3.19%
|
$69,465
$15.3 P/Share
|
|
Mar 04
2025
|
Joseph Fralin Woody |
SELL
Payment of exercise price or tax liability
|
Direct |
18,351
-2.05%
|
$275,265
$15.13 P/Share
|
|
Mar 04
2025
|
Joseph Fralin Woody |
BUY
Exercise of conversion of derivative security
|
Direct |
32,158
+6.63%
|
-
|
|
Mar 04
2025
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,704
-3.05%
|
$70,560
$15.13 P/Share
|
|
Mar 04
2025
|
Mojirade James SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,039
+9.31%
|
-
|
|
Mar 04
2025
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,690
-2.53%
|
$160,350
$15.13 P/Share
|
|
Mar 04
2025
|
Michael Greiner Interim CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,149
+5.37%
|
-
|
|
Mar 04
2025
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
71
-0.35%
|
$1,065
$15.13 P/Share
|
|
Mar 04
2025
|
John Joseph Hurley Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
107
+1.04%
|
-
|
|
Mar 04
2025
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,346
-1.83%
|
$50,190
$15.13 P/Share
|
|
Mar 04
2025
|
Kerr Holbrook SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,145
+5.27%
|
-
|
|
Jan 02
2025
|
Indrani Lall Franchini Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,003
+41.64%
|
-
|
|
Jan 02
2025
|
Lisa Egbuonu Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,003
+31.74%
|
-
|
|
Jan 02
2025
|
Gary Blackford Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,003
+14.36%
|
-
|
|
Jan 02
2025
|
Julie Ann Shimer Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,003
+16.2%
|
-
|
|
Jan 02
2025
|
Patrick J Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,003
+15.26%
|
-
|
|
Dec 03
2024
|
Michael Greiner Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+4.74%
|
-
|
|
Oct 29
2024
|
Michael Greiner Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
44,189
+18.8%
|
-
|
|
Sep 05
2024
|
John Joseph Hurley Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,001
+23.73%
|
-
|
|
Jul 22
2024
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
684
-0.96%
|
$14,364
$21.99 P/Share
|
|
Mar 18
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,596
-2.02%
|
$68,324
$19.09 P/Share
|
|
Mar 18
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,531
+2.74%
|
-
|
|
Mar 18
2024
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,005
-2.92%
|
$171,095
$19.09 P/Share
|
|
Mar 18
2024
|
Michael Greiner Interim CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,219
+2.64%
|
-
|
|
Mar 18
2024
|
Joseph Fralin Woody |
SELL
Payment of exercise price or tax liability
|
Direct |
33,765
-3.77%
|
$641,535
$19.09 P/Share
|
|
Mar 18
2024
|
Joseph Fralin Woody |
BUY
Exercise of conversion of derivative security
|
Direct |
15,821
+3.37%
|
-
|
|
Mar 14
2024
|
Michael Greiner Interim CEO |
SELL
Open market or private sale
|
Direct |
8,000
-0.85%
|
$152,000
$19.14 P/Share
|
|
Mar 11
2024
|
Julie Ann Shimer Director |
BUY
Open market or private purchase
|
Direct |
500
+0.99%
|
$9,500
$19.85 P/Share
|
|
Mar 06
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,618
-2.91%
|
$49,742
$19.0 P/Share
|
|
Mar 06
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,573
+28.94%
|
$694,887
$19.14 P/Share
|
|
Mar 06
2024
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,118
-3.11%
|
$97,242
$19.0 P/Share
|
|
Mar 06
2024
|
Michael Greiner Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
57,471
+25.88%
|
$1,091,949
$19.14 P/Share
|
|
Mar 06
2024
|
Sudhakar Varshney SVP, Global Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
1,394
-4.41%
|
$26,486
$19.0 P/Share
|
|
Mar 06
2024
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,951
-2.67%
|
$37,069
$19.0 P/Share
|
|
Mar 06
2024
|
Mojirade James SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
30,695
+29.62%
|
$583,205
$19.14 P/Share
|
|
Mar 06
2024
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
141
-2.08%
|
$2,679
$19.0 P/Share
|
|
Mar 06
2024
|
John Joseph Hurley Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,829
+21.23%
|
$34,751
$19.14 P/Share
|
|
Mar 06
2024
|
Joseph Fralin Woody |
SELL
Payment of exercise price or tax liability
|
Direct |
8,868
-1.98%
|
$168,492
$19.0 P/Share
|
|
Mar 06
2024
|
Joseph Fralin Woody |
BUY
Grant, award, or other acquisition
|
Direct |
137,147
+23.48%
|
$2,605,793
$19.14 P/Share
|
|
Mar 05
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,502
-2.79%
|
$27,036
$18.76 P/Share
|